Thomas Lund
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Medical Laboratory Technology top 10%
Papers in
- Hematology 23
- Multiple Myeloma Research and Treatments 23
- Oncology 12
- Bone health and treatments 10
- Peptidase Inhibition and Analysis 5
- Co-authors
- Niels Abildgaard (11 shared papers)Mika Kivimäki (1 shared paper)Ebbe Villadsen (1 shared paper)Karl Bang Christensen (1 shared paper)Merete Labriola (1 shared paper)Torben Plesner (8 shared papers)David Sherson (1 shared paper)Ute Bültmann (1 shared paper)
- Journals
- European Journal Of Haematology (5 papers)Journal of the Audio Engineering Society (2 papers)European Journal of Oncology Nursing (2 papers)Blood (2 papers)Cancers (2 papers)
- Partner nations
- DenmarkUnited StatesNorway
In The Last Decade
Thomas Lund
30 papers receiving 658 citations
Peers
Comparison fields: 5 of 81
- Hematology 193
- Medical Laboratory Technology 14
- General Health Professions 155
- Pharmacology 104
- Oncology 159
Countries citing papers authored by Thomas Lund
This map shows the geographic impact of Thomas Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lund more than expected).
Fields of papers citing papers by Thomas Lund
This network shows the impact of papers produced by Thomas Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lund. The network helps show where Thomas Lund may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Lund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 144 | |
| 2 | 2009 | 114 | |
| 3 | 2011 | 64 | |
| 4 | 2019 | 61 | |
| 5 | 2016 | 53 | |
| 6 | 2008 | 45 | |
| 7 | 2008 | 42 | |
| 8 | 2010 | 36 | |
| 9 | 2020 | 35 | |
| 10 | 2010 | 22 | |
| 11 | 2022 | 13 | |
| 12 | 2024 | 7 | |
| 13 | 2020 | 5 | |
| 14 | 2022 | 5 | |
| 15 | Enhanced Localization in 5.1 Production | 2000 | 4 |
| 16 | 2020 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2021 | 2 |
About Thomas Lund
Thomas Lund is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Genetics, having authored 36 papers that have together received 680 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (23 papers), Bone health and treatments (10 papers), Peptidase Inhibition and Analysis (5 papers), Ubiquitin and proteasome pathways (2 papers), Protein Degradation and Inhibitors (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Immunotherapy and Immune Responses (2 papers) and Musculoskeletal pain and rehabilitation (2 papers). The work is most often cited by research in Hematology (193 citations), Medical Laboratory Technology (14 citations), General Health Professions (155 citations), Pharmacology (104 citations) and Oncology (159 citations). Thomas Lund has collaborated with scholars based in Denmark, United States and Norway. Frequent co-authors include Niels Abildgaard, Mika Kivimäki, Ebbe Villadsen, Karl Bang Christensen, Merete Labriola, Torben Plesner, David Sherson, Ute Bültmann, Jens Olsen and Jean‐Marie Delaissé. Their work appears in journals such as European Journal Of Haematology, Journal of the Audio Engineering Society, European Journal of Oncology Nursing, Blood and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.